WASAD Congress 2019

Stress, Anxiety and Mental Health
3 – 5 October | Würzburg, Germany

Wasad Plenary Symposia

Dates and times of the symposia are published under the link "schedule"

Symposium of the SGAD (Schweizerische Gesellschaft für Angst und Depression)
Chair: E. Seifritz, Zurich and S. Walitza, Zurich
1. Predictors of stress resilience, B. Kleim, Zurich
2. The effect of psychosocial and craving-induced stress on social cognition and decision-making in cocaine users: a longitudinal approach, B. Quednow, Zurich
3. The relationship between sleep and brain plasticity and its relevance for psychiatric disorders, R. Huber, Zurich
4. Preclinical view on the mechanism of antidepressant activity of eicosapentaenoic acid, H. Kalkmann,  Basel

Imaging of stress-induced brain functional changes
Chair: M. Walter, Jena and A.J. Fallgatter, Tübingen
1. Imaging stress effects in depression and anxiety, MJ van Tol, Utrecht
2. Imaging of stress-induced brain functional changes, M. Walter, Jena
3. Neuroimaging results from the Leiden Family Lab study on Social Anxiety Disorder: a multiplex, multigenerational endophenotype study, J.M. Bas-Hoogendam, Leiden
4. Temporal unpredictability increases BNST and Amygdala activity during threat processing, N. Siminski, Würzburg

(Maternal) Stress and its consequences: from animals to humans
Chair: B. Derntl, Tübingen and A.J. Fallgatter, Tübingen
1. Stress effects in postpartal depression, L. Galea, Vancouver
2. Stress and its consequences on cognition and emotion in women and men, B. Derntl, Tübingen
3. Psychological outcomes after pediatric hospitalization: the role of trauma type, M. Meentken, Rotterdam
4. Truth lies in the hair: Prenatal hair steroids predict postpartum depression, T. Mikoteit, Solothurn

Adult ADHD and stress: cause or consequence?
Chair: C. Jacob, Esslingen and G. A. Henriquez, Barcelona
1. Cortisol awakening response and ADHD, G.A. Henriquez, Barcelona
2. ADHD and stress-reducing psychotherapy, C. Greven, Nijmegen
3. Attention, eating disorders and body dissatisfaction, F. Esteves, Östersund
4. Chronic stress and quality of life in adult ADHD, S. Kittel-Schneider, Würzburg

Stress and dementia
Chair: P. Riederer, Würzburg and F. Jessen, Cologne
1. The role of stress in the development of dementia, F. Jessen, Cologne
2. Early life stress and its programming effects and lasting consequences, P.J. Lucassen, Amsterdam
3. Stress and neuroinflammation as possible mediators of acute cognitive dysfunction in a streptozotocin-induced rat model of sporadic Alzheimer’s disease, A. Babić Perhoč, Zagreb
4. Anxiety in old age – data of the Vogel study, T. Polak, Würzburg

This symposium is supported by an unrestricted educational grant of the Dr. med. Edda Neele-Stiftung

Temperament, gene and nutrition in anxiety and related disorders
Chair: H. Ozawa, Nagasaki and T. Inoue, Tokyo
1. Relationship between omega-3 fatty acid and mental disorder, K. Yonezawa, Nagasaki
2. Gene-based rare variants association test implicates PLA2G4E as a risk gene for panic disorder, Y.
Morimoto, Nagasaki
3. Temperaments, child abuse and stressful events in anxiety and related disorders, T. Inoue, Tokyo
4. Gene Polymorphisms Are Associated with Treatment-resistant Depression in Han Chinese, Jie Li, Tianjin

Mapping mechanisms of gene x environment interaction in stress - from endophenotype to

Chair: I. Elbau, Munich and T. Halldorsdottir, Reykjavik
1. Neurobiology of self-regulation: Longitudinal influence of FKBP5 early life stress on emotional
and cognitive development in childhood, T. Halldorsdottir, Reykjavik
2. A polygenic score of molecular sensitivity to GR-stimulation maps to stress related changes of
the brains hemodynamic response function, I. Elbau, Munich
3. Interactions between FKBP5 variation and environmental stressors in adolescent major depression, C. Piechaczek, Munich
4. Posttraumatic stress disorder in a war-exposed sample from Balkan countries: The impact of (epi-) genetic variation on disease susceptibility and the severity of symptoms, A. Džubur Kulenović, Sarajevo

Stress resilience and vulnerability
Chair: A. Cattaneo, London and M.A. Riva, Milano
1. Role of miRNA19 in the mechanisms associated with stress vulnerability and stress resilience, A.
Cattaneo, London
2. Molecular signatures of prenatal stress exposure and relevance for the susceptibility and
resilience to mental illness, M.A. Riva, Milano
3. Stress Reactivity in Individuals with High vs Low Interoceptive Accuracy, H. Ghafoor, Würzburg
4. Long-term Effectiveness of Prolonged Exposure for Adolescents with PTSD Using a Task-Shifted Intervention: Randomised Controlled Trial with Supportive Counselling as a Comparator, S. Seedat, Stellenbosch

Clinical targets for stress related and anxiety disorders in children and adolescents
Chair: S. Walitza, Zurich and L. Utens, Amsterdam
1. The link between the genetic risk load, anxiety and stress in individuals at clinical high risk for
psychosis, E. Grünblatt, Zurich
2. Anxiety in children with somatic conditions: outcome of CBT and EMDR for the clinical targets IBD and congenital heart disease, L. Utens, Amsterdam
3. Potential DNA methylation and miRNA markers for posttraumatic stress disorder (PTSD), U. Schmidt, Göttingen
4. Psychological risk factors of gifted adolescents, M. Arakelyan, Yerevan

Clinical perspectives in the treatment of anxiety disorders (Symposium of the GAF)
Chair: K. Domschke, Freiburg and P. Zwanzger, Wasserburg
1. D-cycloserine (DCS) adjunct treatment in combination with cognitive behavioral therapy (CBT),
A. Ströhle, Berlin
2. Prevention of anxiety disorders, M. Schiele, Freiburg
3. Non-invasive brain-stimulation and its impact on extinction learning, M. Hermann, Würzburg
4. Virtual reality as a new tool for the treatment of anxiety, J. Diemer, Wasserburg

Telemedicine and mobile assessment in stress related disorders
Chair: T.J. Renner, Tübingen and G. Skarphedinsson, Reykjavik
1. E-health interventions in pediatric OCD, K. Hollmann, Tübingen
2. Developing and implementing iCBT for pediatric obsessive-compulsive disorder in Iceland, G. Skarphedinsson, Reykjavik
3. An online based stress management intervention for patients with Parkinson’s disease, S. Kleih, Würzburg
4. Clinical, Behavioral and Magnetoencephalographic Correlates of Fear Generalization before and after Virtual Reality Exposure Therapy in Spider Phobia, K. Roesmann, Münster

Anxiety: genetics, social interactions and therapy
Chair: G. Hein, Würzburg and M. Mattheisen, Würzburg
1. OCD genetics: updates from the Danish OCD and Tourette’s study and the Psychiatric Genomics Consortium, M. Mattheisen, Würzburg
2. Genetics and epigenetics of panic disorder, A. Erhardt, Munich
3. Social buffering of anxiety, G. Hein, Würzburg
4. Expectancy violation as mechanism of change in exposure-based cognitive-behavioural therapy, A. Pittig, Würzburg

Anxiety, depression and cognition in brain and heart
Chair: J. Deckert, Würzburg and S. Frantz, Würzburg
1. Investigating the brain-heart connection: the Depression Associated Cardiac Failure (DACFAIL) Study, A. Menke, Würzburg
2. A web-based intervention for improving psychosocial distress in heart failure patients with an implantable cardioverter defibrillator, S.M. Schulz, Würzburg
3. Anxiety, depression and heart function – The genetic connection, S. Kittel-Schneider, Würzburg
4. Cognition matters in patients with chronic heart failure, A. Frey, Würzburg